Previous Close | 6.40 |
Open | 6.78 |
Bid | 7.00 |
Ask | 9.00 |
Strike | 250.00 |
Expire Date | 2024-10-18 |
Day's Range | 6.78 - 6.78 |
Contract Range | N/A |
Volume | |
Open Interest | 132 |
Each of Zimmer Biomet's (ZBH) geographic segments records strong year-over-year sales growth on a reported basis, as well as at CER.
Envista (NVST) registers a year-over-year decline in both segments in the first quarter of 2024.
Investors are optimistic about Quest Diagnostics (DGX) on strong legacy business growth.